Morningstar

Fidelity Advisor Biotechnology Fund - Class C FBTCX

Morningstar Medalist Rating
Unlock
Medalist Rating as of See Fidelity Investment Hub
  • NAV / 1-Day Return $34.96  /  −1.44 %
  • Fund Size $2.4B
  • Adjusted Expense Ratio 1.690%
  • Net Expense Ratio 1.690%
  • Fee Level: Distribution Low
  • Share Class Type Level Load
  • Morningstar Category Health
  • Equity Style Box (Funds) Mid Blend
  • Minimum Initial Investment $0
  • Investment Status Open
  • TTM Yield 1.08%
  • Turnover Ratio 54%
NAV and 1-Day Return as of

Morningstar’s Analysis FBTCX

Will FBTCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable FBTCX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the FBTCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of FBTCX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Advisor Biotechnology C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBTCX

More FBTCX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 46.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

13.83 336M
Healthcare

Gilead Sciences Inc

6.02 146M
Healthcare

Alnylam Pharmaceuticals Inc

3.84 93M
Healthcare

Insmed Inc

3.41 83M
Healthcare

Amylyx Pharmaceuticals Inc

3.38 82M
Healthcare

argenx SE ADR

3.28 80M
Healthcare

Dianthus Therapeutics Inc

3.18 77M
Healthcare

Spyre Therapeutics Inc

3.16 77M
Healthcare

Moderna Inc

3.12 76M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.98 72M
Healthcare

Sponsor Center